MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Olfaction and gray matter volume in Parkinson’s disease. A voxel-based morphometry study

    K. Witt, N. Schmidt, O. Granert, L. Paschen, S. Wolff, G. Deuschl (Kiel, Germany)

    Objective: To evaluate the relation between olfactory functioning and gray matter (GM) volume in patients with Parkinson's disease (PD). Background: Olfactory impairment is one of…
  • 2016 International Congress

    The impact of levodopa and apomorphine on beta- and gamma-oscillations in cortico-basal ganglia circuits in experimental parkinsonism

    J. Kühn, J.K. Haumesser, P.J. Magill, A.A. Kühn, V.V. Nikulin, C. van Riesen (Berlin, Germany)

    Objective: To clarify the role of pathologic oscillations in Parkinson's disease (PD) we recorded local field potentials (LFPs) in cortico-basal ganglia circuits of Parkinsonian and…
  • 2016 International Congress

    Treatment of OFF episodes in Parkinson’s disease: An evaluation of patient and caregiver insights

    E.J. Pappert, N. deGruyther, A. Agro (Toronto, ON, Canada)

    Objective: Evaluate patient and caregiver opinions into the treatment of OFF episodes in patients with Parkinson's disease (PD). Background: OFF episodes are fairly common in…
  • 2016 International Congress

    Colonic microbiome in Korean patients with Parkinson’s disease

    D. Lee, Y.N. Kwon, T.B. Ahn (Seoul, Korea)

    Objective: In this study we investigated the relationship between colonic microbiome and clinical features of the patients with homogeneous ethnicity. Background: Colonic microbiome is an…
  • 2016 International Congress

    Volumetry of the olfactory bulbs and tracts in the differential diagnosis of neurodegenerative parkinsonisms

    M. Menendez Gonzalez, E. Suárez-Sanmartin, C. García, M. Blázquez Estrada (Mieres, Spain)

    Objective: The objective is to assess the use of the volumetry of OB & T as a parameter for distinguishing controls from patients with Parkinson's…
  • 2016 International Congress

    Correlation analysis for postural instability and autonomic dysfunction in patients with Parkinson’s disease

    S. You, S.H. Lim, H. Lee, H.A. Kim (Dague, Korea)

    Objective: To investigate correlation between postural instability and autonomic dysfunction in early stage Parkinson's disease patients. Background: Brainstem pathology may link postural instability (PI) and…
  • 2016 International Congress

    Visual hallucination and pattern of brain degeneration in Parkinson’s disease

    W.W. Lee, E.J. Yoon, J.Y. Lee, S.W. Park, Y.K. Kim (Seoul, Korea)

    Objective: This study was aimed to reveal pattern of brain degeneration related to visual hallucination (VH) throughout different stages of PD. Background: Previous neuroimaging studies…
  • 2016 International Congress

    Changes of brain structure and cognition in individuals with possible prodromal Parkinson’s disease

    M. Heldmann, J. Heeren, L. Rauch, C. Klein, T.F. Münte, M. Kasten, N. Brüggemann (Lübeck, Germany)

    Objective: Investigating brain structure and cognition in healthy individuals with positive Parkinson's disease (PD) risk markers (hyposmia, increased hyperechogenic area of the substantia nigra). Background:…
  • 2016 International Congress

    The efficacy of quantitative 99mTc-TRODAT-1 SPECT in diagnosis of aged patients with Parkinson’s disease

    C.F. Lee, C.Y. Wei, G.U. Huang, I.J. Chen, B. Hsu (Changhua, Taiwan)

    Objective: We aim to establish the normal reference with quantitative 99mTc-Trodat-1 (TRODAT) SPECT and verify the diagnostic performance in aged Parkinson's disease (PD) patients. Background:…
  • 2016 International Congress

    Detecting brainstem changes in Parkinson’s disease using quantitative MRI

    C. Lambert, A. Lutti, B. Draganski, T. Foltynie (London, United Kingdom)

    Objective: 1. Can brainstem changes be detected using quantitative MRI (qMRI). 2. How many subjects would be required to detecting changes in brainstem regions affected…
  • « Previous Page
  • 1
  • …
  • 362
  • 363
  • 364
  • 365
  • 366
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #24475 (not found)
  • Preclinical characterization of UCB0022, an oral, brain penetrant, selective, clinical-stage positive allosteric modulator of the dopamine 1 receptor (D1 PAM)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley